Autonomix Medical (AMIX) Fundamental Analysis: Revenue, Earnings & Valuation

0.56 / 10

Underperform

Fundamental rating is Underperform with a 0.6/10 score. Asset‑MV and Profit‑MV are relatively strong, yet Revenue‑MV, Cash‑MV, ROA and profit margins are negative, reflecting poor earnings and cash generation. The balance sheet appears defensive but financially fragile.

Analysis Checks(2/10)

Revenue-MV

Value-0.11

Score0/3

Weight17.79%

1M Return-4.18%

ROA (%)

Value-118.77

Score0/3

Weight19.65%

1M Return-6.58%

Net cash flow from operating activities / Operating revenue (%)

Value-982.50

Score0/3

Weight19.70%

1M Return-6.63%

Profit-MV

Value0.66

Score2/3

Weight-16.80%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-118.77

Score0/3

Weight19.65%

1M Return-6.58%

EBIT / Total operating revenue (%)

Value-1049.47

Score0/3

Weight19.70%

1M Return-5.19%

Asset-MV

Value0.35

Score3/3

Weight-25.53%

1M Return4.62%

Net profit / Total operating revenue (%)

Value-654.10

Score0/3

Weight20.06%

1M Return-6.68%

Cash-MV

Value0.02

Score1/3

Weight15.93%

1M Return-4.16%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight9.84%

1M Return-2.39%

Is AMIX fundamentally strong?

AMIX scores 0.56/10 on fundamentals and holds a Premium valuation at present. Backed by its -168.66% ROE, 0.00% net margin, -0.26 P/E ratio, 0.53 P/B ratio, and 70.06% earnings growth, these metrics solidify its Underperform investment rating.